Pyroptosis-Related Gene Signature Is a Novel Prognostic Biomarker for Sarcoma Patients

Figure 6

Immune cell components of tumour microenvironment in sarcoma. (a) Comparison of 22 immune cell types between the two risk cohorts. (b) Comparison of four major classes of immune cell types in sarcoma.

(a)

(b)